| Financial Year |
March 31 2023 |
| Monetary Funds |
11,732,033.97 |
| Held-for-trading Financial Assets |
160,228,310.55 |
| Notes Receivable |
425,365.00 |
| Accounts Receivable |
65,887,518.80 |
| Advances to Suppliers |
13,414,490.98 |
| Other Receivables |
2,089,968.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
57,947,553.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
24,407,464.59 |
| Total Current Assets |
338,630,783.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
12,791,187.33 |
| Fixed Assetes |
236,666,796.32 |
| Under-construction Projects |
152,539,898.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
50,748,641.25 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
1,002,586.32 |
| Other Non-Current Assets |
18,386,157.98 |
| Sub-Total of Non-Current Assets |
472,639,298.90 |
| Total Assets |
811,270,082.05 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
32,932,121.17 |
| Accounts Received In Advance |
40,324.15 |
| Employee Compensation Payable |
4,472,298.50 |
| Taxes Payable |
2,618,615.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,865,574.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
40,073,692.78 |
| Other Current Liabilities |
171,246.61 |
| Sub-Total of Current Liabilities |
82,649,378.17 |
| Long-term Loans |
20,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,867.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
43,459,907.01 |
| Total Liabilities |
126,109,285.18 |
| Paid-In Capital(Or Share Stock) |
202,620,000.00 |
| Capital Surplus |
554,912.56 |
| Surplus Reserve |
70,089,016.22 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
381,124,260.50 |
| Minority Stockholder's Interest |
30,772,607.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
654,388,189.28 |
| Owner's Equity（Stockholder's Equity） |
685,160,796.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
811,270,082.05 |
